share_log

Alliance Global Partners Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $2.2

Alliance Global Partners Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $2.2

Alliance Global Partners維持買入NeuroOne Medical Tech,將目標
Benzinga ·  2023/08/15 10:51

Alliance Global Partners analyst Ben Haynor maintains NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy and lowers the price target from $3.25 to $2.2.

Alliance Global Partners分析師本·海諾維持NeuroOne Medical Tech(納斯達克股票代碼:NMTC)的買入,並將目標股價從3.25美元下調至2.2美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論